X Marks the Spot –
April 18, 2018 – Research has already been done in the US into using MDMA to treat post-traumatic stress disorder (PTSD) with the aim to get the drug licensed as therapeutic medicine by 2021. However, this is the world’s first ever study looking at if the drug is similarly beneficial for treating addiction. Candidates in contact with Bristol’s drug services are going on a detox and receiving a course of MDMA-assisted therapy … Dr Ben Sessa, a consultant child and adolescent psychiatrist and senior research fellow at Imperial College London, who specialises in mental health and addiction, is leading the study.